Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.

Hypoglycemia is associated with increased risk of cardiovascular adverse clinical outcomes. There is evidence that impaired glucose tolerance (IGT) is associated with cardiovascular morbidity and mortality. Whether IGT individuals have asymptomatic hypoglycemia under real-life conditions that are re...

Full description

Bibliographic Details
Main Authors: Ersilia Castaldo, Donata Sabato, Davide Lauro, Giorgio Sesti, Maria Adelaide Marini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3229545?pdf=render
id doaj-66b94fbb578f42c2a6171d89a93b2efc
record_format Article
spelling doaj-66b94fbb578f42c2a6171d89a93b2efc2020-11-25T02:04:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01612e2831210.1371/journal.pone.0028312Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.Ersilia CastaldoDonata SabatoDavide LauroGiorgio SestiMaria Adelaide MariniHypoglycemia is associated with increased risk of cardiovascular adverse clinical outcomes. There is evidence that impaired glucose tolerance (IGT) is associated with cardiovascular morbidity and mortality. Whether IGT individuals have asymptomatic hypoglycemia under real-life conditions that are related to early atherosclerosis is unknown. To this aim, we measured episodes of hypoglycemia during continuous interstitial glucose monitoring (CGM) and evaluated their relationship with early manifestation of vascular atherosclerosis in glucose tolerant and intolerant individuals. An oral glucose tolerance test (OGTT) was performed in 79 non-diabetic subjects. Each individual underwent continuous glucose monitoring for 72 h. Cardiovascular risk factors and ultrasound measurement of carotid intima-media thickness (IMT) were evaluated. IGT individuals had a worse cardiovascular risk profile, including higher IMT, and spent significantly more time in hypoglycemia than glucose-tolerant individuals. IMT was significantly correlated with systolic (r = 0.22; P = 0.05) and diastolic blood pressure (r = 0.28; P = 0.01), total (r = 0.26; P = 0.02) and LDL cholesterol (r = 0.27; P = 0.01), 2-h glucose (r = 0.39; P<0.0001), insulin sensitivity (r = -0.26; P = 0.03), and minutes spent in hypoglycemia (r = 0.45; P<0.0001). In univariate analyses adjusted for gender, minutes spent in hypoglycemia were significantly correlated with age (r = 0.26; P = 0.01), waist circumference (r = 0.33; P = 0.003), 2-h glucose (r = 0.58; P<0.0001), and 2-h insulin (r = 0.27; P = 0.02). In a stepwise multivariate regression analysis, the variables significantly associated with IMT were minutes spent in hypoglycemia (r(2) = 0.252; P<0.0001), and ISI index (r(2) = 0.089; P = 0.004), accounting for 34.1% of the variation. Episodes of hypoglycemia may be considered as a new potential cardiovascular risk factor for IGT individuals.http://europepmc.org/articles/PMC3229545?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ersilia Castaldo
Donata Sabato
Davide Lauro
Giorgio Sesti
Maria Adelaide Marini
spellingShingle Ersilia Castaldo
Donata Sabato
Davide Lauro
Giorgio Sesti
Maria Adelaide Marini
Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.
PLoS ONE
author_facet Ersilia Castaldo
Donata Sabato
Davide Lauro
Giorgio Sesti
Maria Adelaide Marini
author_sort Ersilia Castaldo
title Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.
title_short Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.
title_full Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.
title_fullStr Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.
title_full_unstemmed Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.
title_sort hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description Hypoglycemia is associated with increased risk of cardiovascular adverse clinical outcomes. There is evidence that impaired glucose tolerance (IGT) is associated with cardiovascular morbidity and mortality. Whether IGT individuals have asymptomatic hypoglycemia under real-life conditions that are related to early atherosclerosis is unknown. To this aim, we measured episodes of hypoglycemia during continuous interstitial glucose monitoring (CGM) and evaluated their relationship with early manifestation of vascular atherosclerosis in glucose tolerant and intolerant individuals. An oral glucose tolerance test (OGTT) was performed in 79 non-diabetic subjects. Each individual underwent continuous glucose monitoring for 72 h. Cardiovascular risk factors and ultrasound measurement of carotid intima-media thickness (IMT) were evaluated. IGT individuals had a worse cardiovascular risk profile, including higher IMT, and spent significantly more time in hypoglycemia than glucose-tolerant individuals. IMT was significantly correlated with systolic (r = 0.22; P = 0.05) and diastolic blood pressure (r = 0.28; P = 0.01), total (r = 0.26; P = 0.02) and LDL cholesterol (r = 0.27; P = 0.01), 2-h glucose (r = 0.39; P<0.0001), insulin sensitivity (r = -0.26; P = 0.03), and minutes spent in hypoglycemia (r = 0.45; P<0.0001). In univariate analyses adjusted for gender, minutes spent in hypoglycemia were significantly correlated with age (r = 0.26; P = 0.01), waist circumference (r = 0.33; P = 0.003), 2-h glucose (r = 0.58; P<0.0001), and 2-h insulin (r = 0.27; P = 0.02). In a stepwise multivariate regression analysis, the variables significantly associated with IMT were minutes spent in hypoglycemia (r(2) = 0.252; P<0.0001), and ISI index (r(2) = 0.089; P = 0.004), accounting for 34.1% of the variation. Episodes of hypoglycemia may be considered as a new potential cardiovascular risk factor for IGT individuals.
url http://europepmc.org/articles/PMC3229545?pdf=render
work_keys_str_mv AT ersiliacastaldo hypoglycemiaassessedbycontinuousglucosemonitoringisassociatedwithpreclinicalatherosclerosisinindividualswithimpairedglucosetolerance
AT donatasabato hypoglycemiaassessedbycontinuousglucosemonitoringisassociatedwithpreclinicalatherosclerosisinindividualswithimpairedglucosetolerance
AT davidelauro hypoglycemiaassessedbycontinuousglucosemonitoringisassociatedwithpreclinicalatherosclerosisinindividualswithimpairedglucosetolerance
AT giorgiosesti hypoglycemiaassessedbycontinuousglucosemonitoringisassociatedwithpreclinicalatherosclerosisinindividualswithimpairedglucosetolerance
AT mariaadelaidemarini hypoglycemiaassessedbycontinuousglucosemonitoringisassociatedwithpreclinicalatherosclerosisinindividualswithimpairedglucosetolerance
_version_ 1724944904019247104